CPG Webinar – Case Studies in Immune Checkpoint Inhibitor-related Adverse Events

When:  Oct 6, 2021 from 19:00 to 20:00 (ET)
18CIG-logo-rgb.jpgOn Wednesday, October 6, 2021 from 7–8 p.m. ET, join leading experts from the SITC Immune Checkpoint Inhibitor-related Adverse Events Guideline Expert Panel for the "SITC Clinical Practice Guideline Webinar – Case Studies in Immune Checkpoint Inhibitor-related Adverse Events." This high-level webinar will include case studies that illustrate execution of guideline recommendations, as well as discussion on difficult topics related to case management.

Upon completion of this program, participants will be able to:

  1. Outline considerations for treating high-risk patients with immune checkpoint inhibitors​
  2. Determine appropriate management of patients with multiple or sequential irAEs​
  3. Identify management strategies for uncommon and/or steroid refractory immune-related toxicities

Webinar Faculty:

  • Co-Moderator: Julie R. Brahmer, MD, MSc — Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (Expert Panel Chair)
  • Co-Moderator: Marc S. Ernstoff, MD — National Institute of Health (Expert Panel Chair)
  • Laura Cappelli, MD, MHS, MS — Johns Hopkins University (Expert Panel Member)
  • Bianca D. Santomasso, MD, PhD — Memorial Sloan Kettering Cancer Center (Expert Panel Member)
  • Mario Lacouture, MD — Memorial Sloan Kettering Cancer Center (Expert Panel Member)


REGISTER NOW


The Practical Management Pearls and Case Studies Webinars are part of the Cancer Immunotherapy Clinical Practice Guidelines Advanced Webinar Series supported, in part, by grants from Amgen and Merck & Co., Inc. (as of 9/15/2021).
0c5fc50a2c9f4300afadbcc55b201f99.jpg
The SITC Clinical Practice Guidelines are produced and funded solely by SITC. No outside funding is received for the development of the manuscripts.


#ImmuneCheckpointInhibitors #AdverseEvents #ClinicalPracticeGuideline #Webinar #2021 #NoCEOffered
​​​